We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries New sponsored testing program leverages Myriad’s MyChoice Tests for patients with high-grade serous ovarian...
Nuevo estudio publicado en Clinical Cancer Research Journal destaca el uso de la prueba EndoPredict para informar el tratamiento en pacientes premenopáusicas con cáncer de mama La prueba...
Myriad Genetics s'associe à l'Institut für Hämopathologie Hamburg et au Centre Georges-François Leclerc pour étendre l'accès aux tests génétiques en Europe Cette collaboration...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 35.68 | 35.68 | 35.68 | 738 | 35.68 | DE |
4 | 0 | 0 | 35.68 | 35.68 | 35.68 | 952 | 35.68 | DE |
12 | 0 | 0 | 35.68 | 35.68 | 35.68 | 424 | 35.68 | DE |
26 | 0 | 0 | 35.68 | 35.68 | 35.68 | 289 | 35.68 | DE |
52 | 0 | 0 | 35.68 | 35.68 | 35.68 | 209 | 35.68 | DE |
156 | 0 | 0 | 35.68 | 35.68 | 35.68 | 92 | 35.68 | DE |
260 | 0 | 0 | 35.68 | 35.68 | 35.68 | 69 | 35.68 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions